GPs begin prescribing weight-loss jabs on the NHS 

GPs begin prescribing weight-loss jabs on the NHS 

GPs begin prescribing weight-loss jabs on the NHS in England. GPs can now prescribe Mounjaro (tirzepatide) to combat obesity for the first time via the NHS. Initially, eligibility is limited to around 220,000 severely obese patients (BMI over 40) with at least four related health conditions, including type 2 diabetes, hypertension, heart disease or sleep apnoea. This marks a shift from specialist-only access to GP-led prescribing over the next three years, with future expansion to around three million people with a BMI over 35 anticipated.

Read a WTX News report on the weight-loss jabs

🔁 Reactions:

• Government (Health Secretary Wes Streeting): “This rollout is about universal access to revolutionary treatments, not just for those who can afford them.”
  
• Opposition (Royal College of GPs): “While promising, this mustn’t be seen as a silver bullet—GP workloads and proper training are crucial.” (news.sky.com)
  
• Viral/Public (r/mounjarouk Reddit): “That’s not the guidelines at all… the article clearly says 40 and 4 conditions.” indicating confusion over rollout details (reddit.com)
  

📰 Bias Snapshot:

• Sky/AP/Reuters present balanced reporting: the eligibility rules, patient numbers, GP capacity concerns, and prevention strategy are clearly laid out.
  
• The Guardian highlights both the record-breaking scale of the rollout and cautionary notes against overreliance on pharmacotherapy (theguardian.com).
  
• The Sun sensationalises with headlines like “fat jabs”, stressing side effects and private users versus NHS patients with alarmist tones (thesun.co.uk).
  

📊 Sentiment: Neutral–positive.